Minoxidil is a synthetic small molecule belonging to the class of potassium channel openers, chemically a pyrimidine N-oxide derivative. In scientific research, it is studied as a model compound for ion channel biophysics and as a reference standard in analytical work. This compound is offered as 5 mg tablets, exclusively for laboratory and research purposes.<\/p>\n
Minoxidil (2,4-diamino-6-piperidinopyrimidine-3-oxide) is a small organic molecule that belongs to the openers of ATP-sensitive potassium channels (KATP<\/sub>-channels). The structure combines a diaminopyrimidine core with a piperidine ring and an N-oxide function, an arrangement that makes the compound a widely used model in the study of potassium channel modulation and associated membrane biophysics.<\/p>\n In research models, Minoxidil itself serves as the starting compound: enzymatic conversion by sulfotransferases yields the sulfate metabolite minoxidil sulfate, the form that exhibits the strongest interaction with the potassium channel in vitro. This two-step biotransformation makes the compound interesting for enzymological and receptor-oriented laboratory research. Consequently, Minoxidil is used as a model compound and reference substance within scientific research.<\/p>\n In a laboratory context, Minoxidil occurs in the following research areas, among others:<\/p>\n Var och en av dessa till\u00e4mpningar involverar kontrollerad laboratorie- eller preklinisk modellforskning.<\/p>\n Minoxidil falls under the category of oral investigation compounds in solid tablet form within our range. Researchers working with this category frequently combine the compound with other small molecules that are studied via their own biochemical targets. While Minoxidil focuses on the modulation of ATP-sensitive potassium channels, other components within the same product line have been specifically chosen to cover various enzymatic or receptor-linked targets. These compounds share the oral tablet form but differ fundamentally in molecular class and investigated mechanism.<\/p>\n Minoxidil is supplied as solid tablets with a standardized amount of 5 mg per tablet, packaged in quantities of 100. Unlike freeze-dried peptides, this solid form does not require reconstitution; the tablets can be weighed directly in a laboratory setup or, if necessary, dissolved in a suitable solvent for further analysis.<\/p>\n Store the tablets dry at room temperature, protected from direct light and moisture, in the original packaging. Observe the compound with the usual laboratory precautions: work in a clean environment, use suitable personal protective equipment, and prevent cross-contamination with other research materials. Keep the packaging out of reach of unauthorized persons.<\/p>\n For this compound, the content is expressed as the amount of active substance per tablet (5 mg per tablet) rather than as a purity percentage, as is customary for tablet and capsule formulations.<\/p>\nForskningsomr\u00e5den<\/h2>\n
\n
Minoxidil in our research assortment<\/h2>\n
Specifikationer<\/h2>\n
\n\n
\n \nSpecifikation<\/th>\n V\u00e4rde<\/th>\n<\/tr>\n<\/thead>\n \n Prov<\/td>\n Minoxidil<\/td>\n<\/tr>\n \n Synonymer<\/td>\n 2,4-diamino-6-piperidinopyrimidine-3-oxide; 6-(1-piperidinyl)-2,4-pyrimidinediamine-3-oxide<\/td>\n<\/tr>\n \n CAS-nummer<\/td>\n 38304-91-5<\/td>\n<\/tr>\n \n Molekylformel \/ vikt<\/td>\n C9<\/sub>H15<\/sub>N5<\/sub>O \/ 209.25 Da<\/td>\n<\/tr>\n \n PubChem CID<\/td>\n 4201<\/td>\n<\/tr>\n \n Klass<\/td>\n Small molecule, opener of ATP-sensitive potassium channels<\/td>\n<\/tr>\n \n Form<\/td>\n Tablets<\/td>\n<\/tr>\n \n Amount per tablet<\/td>\n 5 mg<\/td>\n<\/tr>\n \n Number of tablets per package<\/td>\n 100<\/td>\n<\/tr>\n \n Lagring<\/td>\n Store in a dry place at room temperature, protected from light and moisture.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Form, hantering och f\u00f6rvaring<\/h2>\n
Sammans\u00e4ttning och labresultat<\/h2>\n